Liver Metastases Treatment

Selection depends on several interacting factors rather than a single feature. Clinicians consider the original cancer, the number and location of liver lesions, molecular characteristics, previous treatments, and the patient’s overall health. They also weigh whether disease control requires treatment throughout the body, direct control of liver tumors, or a combination of both approaches.

Systemic treatments such as chemotherapy, targeted therapy, immunotherapy, or hormone therapy act throughout the body, addressing cancer beyond the liver. Local approaches, including surgery, ablation, embolization, or radiation, directly destroy or control liver tumors. Combining these categories may address both the broader disease and the immediate effects of tumor burden on liver function.

Molecular features help shape treatment selection alongside the primary cancer, tumor distribution, and prior therapy. They may support consideration of systemic options such as targeted therapy or immunotherapy, while other clinical factors determine whether local treatment is appropriate. In cancer research, incorporating these features supports more precise treatment combinations rather than relying only on tumor location.

Planning begins by characterizing the original cancer, the number and location of liver lesions, relevant molecular features, previous treatment exposure, and overall health. The care team then weighs systemic therapies against liver-directed procedures, or considers both. This process aims to control tumor burden while accounting for liver function, treatment feasibility, and the patient’s broader disease.

These approaches control tumors in different ways. Surgery removes liver tumor tissue, ablation destroys tumors locally, embolization controls tumors through treatment directed to their blood supply, and radiation uses focused energy to damage tumor cells. The choice depends on lesion number and location, overall health, and how directly the liver disease needs to be controlled.

Research evaluates whether treatment strategies can control liver tumor burden, preserve liver function, extend survival, and improve outcomes for patients with advanced cancer. It also investigates how to monitor disease more effectively and select combinations more precisely. Comparing systemic and local approaches, including their use together, helps refine treatment decisions for different disease patterns.